Abstract
Subject
Publication details
- Journal
- Oman Medical Journal
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
- License
- CC BY-NC 4.0
Cite this article
APA 7
Nagy, A., Yaqut, M., Abbas, D., & Mohamed, A. (2026). Subacute Thyroiditis Following the Third Dose of SARS-CoV-2 mRNA (Pfizer-BioNTech) Vaccine for COVID-19 in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report. Oman Medical Journal. https://omanscience.com/en/articles/subacute-thyroiditis-following-the-third-dose-of-sars-cov-2-mrna-pfizer-biontech-vaccine-for-covid-19-in-a-patient-with-clear-cell-renal-cell-carcinom
MLA 9
Nagy, Amro, et al. "Subacute Thyroiditis Following the Third Dose of SARS-CoV-2 mRNA (Pfizer-BioNTech) Vaccine for COVID-19 in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report." Oman Medical Journal, 2026. https://omanscience.com/en/articles/subacute-thyroiditis-following-the-third-dose-of-sars-cov-2-mrna-pfizer-biontech-vaccine-for-covid-19-in-a-patient-with-clear-cell-renal-cell-carcinom.
Chicago (author–date)
Nagy, Amro, Muhammad Yaqut, Doaa Abbas, and Amna Mohamed. 2026. "Subacute Thyroiditis Following the Third Dose of SARS-CoV-2 mRNA (Pfizer-BioNTech) Vaccine for COVID-19 in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report." Oman Medical Journal. https://omanscience.com/en/articles/subacute-thyroiditis-following-the-third-dose-of-sars-cov-2-mrna-pfizer-biontech-vaccine-for-covid-19-in-a-patient-with-clear-cell-renal-cell-carcinom.
Harvard
Nagy, A., Yaqut, M., Abbas, D. and Mohamed, A. (2026) 'Subacute Thyroiditis Following the Third Dose of SARS-CoV-2 mRNA (Pfizer-BioNTech) Vaccine for COVID-19 in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report', Oman Medical Journal. Available at: https://omanscience.com/en/articles/subacute-thyroiditis-following-the-third-dose-of-sars-cov-2-mrna-pfizer-biontech-vaccine-for-covid-19-in-a-patient-with-clear-cell-renal-cell-carcinom.
Vancouver
Nagy A, Yaqut M, Abbas D, Mohamed A. Subacute Thyroiditis Following the Third Dose of SARS-CoV-2 mRNA (Pfizer-BioNTech) Vaccine for COVID-19 in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report. Oman Medical Journal. 2026. https://omanscience.com/en/articles/subacute-thyroiditis-following-the-third-dose-of-sars-cov-2-mrna-pfizer-biontech-vaccine-for-covid-19-in-a-patient-with-clear-cell-renal-cell-carcinom
IEEE
A. Nagy, M. Yaqut, D. Abbas, and A. Mohamed, "Subacute Thyroiditis Following the Third Dose of SARS-CoV-2 mRNA (Pfizer-BioNTech) Vaccine for COVID-19 in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report," Oman Medical Journal, 2026, https://omanscience.com/en/articles/subacute-thyroiditis-following-the-third-dose-of-sars-cov-2-mrna-pfizer-biontech-vaccine-for-covid-19-in-a-patient-with-clear-cell-renal-cell-carcinom.